Press Release (ePRNews.com) - LOS ALTOS, Calif. - Feb 21, 2019 - Bioz, Inc., a Silicon Valley A.I. data company, is proud to announce a new partnership with BioVendor, Inc., an innovative biotechnology leader focused on developing and manufacturing in vitro diagnostic and for-research-use immunoassays, antibodies and recombinant proteins. By combining the latest advances in Natural Language Processing (NLP) and Machine Learning (ML), Bioz enables researchers in academia and biopharma to access real-world use-cases that come directly from scientific articles. This allows BioVendor to further incorporate transparency, increase researcher confidence, and improve the overall experience of researchers who visit their website.
BioVendor’s R&D efforts are aimed at rapidly growing fields of interest within the international research and diagnostic community, such as obesity, metabolic syndrome, diabetes, cardiovascular diseases, renal disease and injury, bone metabolism, osteoporosis, infection and inflammation, immune response disorders, oncology, tumor markers, neurological diseases and aging-associated diseases.
Bioz’ proprietary A.I. software mines 27 million scientific articles for product-specific data, and then structures this objective information into product recommendations that are incredibly valuable for the entire scientific community. Because peer-reviewed life science articles detail product usage in experiments, scientists consider articles to be their most trusted reference point when selecting products to purchase for their own experiments.
With its platform, Bioz facilitates a clearer, faster and more cost-effective product selection journey than was possible before Bioz was available. With this partnership, BioVendor is now able to display its most recent and relevant product citations on each of its website’s product pages via live-streamed Bioz badges. The badges also feature the Bioz Stars score, an objective rating that adheres to a policy of ZERO BIAS™.
“I am excited to partner with BioVendor to provide their researchers with peer-reviewed product specific data,” said Dr. Karin Lachmi, co-founder and CSO of Bioz. “BioVendor is a manufacturer of highly-cited immunoassays, antibodies and recombinant proteins, products that play a key role in many diagnostic and for-research-use assays. This partnership surfaces the latest BioVendor product citations, enhancing transparency and objectivity, and thus supporting researchers.”
“For many years we have been collecting citation data manually ourselves, a time-consuming and inefficient process. With our new live-streamed Bioz badges, we are able to display real case-studies, and real scientific data relating to our products, which is immensely helpful for when researchers plan and perform their experiments,” said Vladimir Kolar, Director of Marketing at BioVendor. Vladimir added that “they are seeing high levels of user interaction with Bioz badges, which is leading to well-informed purchase decisions.”
Suggested Tweet: @BioVendor leverages @Bioz A.I. software to bring transparency and confidence to its researcher users. https://bit.ly/2BLHXHt
About Bioz, Inc.
Bioz is the world’s most advanced A.I. search engine for life science experimentation, empowering scientists in biopharma and academia to accelerate their research towards new discoveries. Bioz guides scientists to the most-validated and cost-effective products to use in their experiments by providing them with evidence-based product recommendations. These recommendations have been reverse-engineered from real-world experiments, as described in over 500 million pages of scientific text from peer-reviewed articles. The result: Bioz.com, the world’s most comprehensive source of life science product recommendations and experimentation guidance, covering over 300 million products, 50,000 suppliers, 12 million images, and over 5 billion protocol conditions and associated techniques, enabling researchers to work faster and more cost-effectively, generating more successful and impactful outcomes.
Bioz A.I. was developed by an experienced team of software engineers, led by A.I. experts from Microsoft and Google and Nobel Prize winners in chemistry. The technology incorporates proprietary cutting-edge NLP, ML, neural networks, deep learning, and domain-specific named-entity recognition, entity matching, and entity linking algorithms. What used to take scientists months, now takes them mere minutes with Bioz, 82x times faster than before. By accelerating the pace of experiments, Bioz is accelerating the pace of drug discovery by as much as 50%, which translates into billions of research dollars saved. With objectivity, transparency, and trustworthiness, Bioz empowers researchers in the top 25 biopharma companies, and in more than 12,000 academic institutions in 196 countries.
To learn more about the Bioz Partner Program, please reach out to firstname.lastname@example.org.
About BioVendor, Inc.
BioVendor – Research & Diagnostic Products, a division of BioVendor – Laboratorní medicína a.s., Brno, Czech Republic (Est. 1992) is an innovative biotechnology company focused on developing and manufacturing in vitro diagnostic and for-research-use immunoassays, antibodies and recombinant proteins. BioVendor’s R&D efforts are aimed at rapidly growing fields of interest within the international research and diagnostic community, with a primary focus on the global epidemic lifestyle and civilization diseases. Recently they have also been focusing on novel topics known to be of great interest among the scientific and diagnostic community – microRNA biomarkers, liquid biopsy, exosome isolation, and immunodiagnostic multiplexing and automation. Their products are the result of long-term R&D, based on the capabilities of their research professionals to set new targets and to develop and manufacture new products, some of which are unique in the market. BioVendor’s demanding customers include many of the world’s top-ranking scientific institutions. BioVendor has four sales branches and more than sixty distributors, creating a complete end-to-end workflow with enhanced service and technical support.
BioVendor – Laboratorni medicina a.s., is EN ISO 13485:2003, ISO 9001:2008 and ISO 14001:2004 certified, assuring that the development and manufacturing processes of all of their products meet all required quality control and environmental management criteria. BioVendor – Research & Diagnostic Products is a member of BioVendor Group, an international company providing a broad range of IVD technologies and capabilities including, in-house development and manufacturing of immunoassays and molecular diagnostics for the clinical market, as well as a broad offering for the Life Science market. BioVendor has an extensive track record of acquisitions including, TestLine Clinical Diagnostics (Czech Republic), ViennaLab Diagnostics (Austria), Oxford Biosystems (UK), and most recently, in September 2017, DIAsource Immuno-Assays (Belgium).
To learn more about BioVendor, please visit biovendor.com Source :